Jack Wenik, Member of the Firm in the Health Care & Life Sciences and Litigation practices, in the firm’s Newark office, was quoted in Inside Health Policy, in “FDA Urges Supplement Industry to Push for Product Listing,” by Luke Zarzecki. (Read the full version – subscription required.)
Following is an excerpt:
FDA is urging the dietary supplement industry to lobby Congress to require product listing, with one official saying the agency plans to focus on programmatic reforms first after scrapping a request it made in prior years for congressional authority to mandate supplement makers list ingredients. …
Earlier this month, FDA informed the dietary supplement industry it is loosening a requirement that labels disclose supplemental health claims have not been evaluated by FDA, a move industry cheered as a positive step to prevent unnecessary litigation but consumer advocates said could mislead purchasers.
Meanwhile, parts of the dietary supplement industry support product listing, with the Council for Responsible Nutrition (CRN) and the Consumer Healthcare Products Association (CHPA) both saying they would like to see product listing enacted. But Jack Wenik, an attorney at Epstein Becker & Green, said at the conference "my clients (are) always freaking out that the FDA is actually going to require a listing of all the products to create some sort of official database." …
